Why selective screening for asymptomatic carotid stenosis is Currently appropriate: a special report

This article presents the rationale for such a program.AREAS COVERED: The benefits of selective screening for AsxCS include early recognition of AsxCS allowing timely initiation of preventive measures to reduce future myocardial infarction (MI), stroke, cardiac death and cardiovascular (CV) event rates.EXPERT OPINION: Mass screening programs for AsxCS are neither clinically effective nor cost-effective. Nevertheless, targeted screening of populations at high risk for AsxCS provides an opportunity to identify these individuals earlier rather than later and to initiate a number of lifestyle measures, risk factor modifications and intensive medical therapy in order to prevent future strokes and CV events. For patients at 'higher risk of stroke' on best medical treatment, a prophylactic carotid intervention may be considered.PMID:38480465 | DOI:10.1080/14779072.2024.2330660

Source: Expert Review of Cardiovascular Therapy - March 13, 2024 Category: Cardiology Authors: Kosmas I Paraskevas Alan Dardik Marc L Schermerhorn Christos D Liapis Armando Mansilha Brajesh K Lal William A Gray Martin M Brown Piotr Myrcha Carl J Lavie Clark J Zeebregts Eric A Secemsky Luca Saba Matthew Blecha Victor Gurevich Mauro Silvestrini Ales Source Type: research